Ledger.Open graph →
SEC Form D · filed January 4, 2012

ACCELERON PHARMA INC

Offering
$30.5M
Sold
$30.5M
Exemption
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

People & firms on this filing (30)

George S. Golumbeski · CAMBRIDGE, MADirectorTerrance G. Mcguire · CAMBRIDGE, MADirectorJohn Knopf · CAMBRIDGE, MAExec · DirectorKevin F. Mclaughlin · CAMBRIDGE, MAExecRichard F. Pops · CAMBRIDGE, MADirectorSteven L. Ertel · CAMBRIDGE, MAExecRobert L. Steininger · CAMBRIDGE, MAExecJean M. George · CAMBRIDGE, MADirectorAnthony B. Evnin · CAMBRIDGE, MADirectorTom W. Maniatis · CAMBRIDGE, MADirectorMatthew L. Sherman · CAMBRIDGE, MAExecCarl L. Gordon · CAMBRIDGE, MADirectorJoseph S. Zakrzewski · CAMBRIDGE, MADirectorWylie W. Vale · CAMBRIDGE, MADirectorEdwin M. Kania · CAMBRIDGE, MADirectorErik Pampalone · Chatsworth, CAExec · DirectorDavid Turnerr · San Diego, CAExecJohn Montieth · San Diego, CADirectorJeffrey Closs · Palo Alto, CADirectorGuido Neels · Palo Alto, CADirectorCharles S. Taylor · Palo Alto, CADirectorThomas A. Proulx · San Francisco, CADirectorJed Katz · San Francisco, CADirectorSteven B. Jaffee · Indianapolis, INExecRobert Segal · TORONTO, Ontario, CanadaExecWilliam Holland · TORONTO, Ontario, CanadaExecWilliam Fielding · TORONTO, Ontario, CanadaDirectorWilliam Levy · TORONTO, Ontario, CanadaDirectorHarp Gahunia · TORONTO, Ontario, CanadaDirectorEdwin M. Kania · Watertown, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗